Title:
抗腫瘍性のCCI-779及びリツキシマブの組み合わせ
Document Type and Number:
Japanese Patent JP2007528399
Kind Code:
A
Abstract:
This invention provides the use of a combination of CCI-779 and rituximab in the treatment of non-Hodgkin's lymphoma.
More Like This:
| JP2019055980 | METHOD OF ENHANCING DELIVERY OF THERAPEUTIC COMPOUNDS TO EYE |
| WO/2018/229249 | METHOD FOR THE TREATMENT OF IMMUNE THROMBOCYTOPENIA |
| JP2022508529 | Double target antigen binding molecule |
Inventors:
Bayever, Eleele
Mole, Lawrence
Sherman, Matthew, Elle.
Allen, Lee, F.
Strass, Lewis, Sea.
Mole, Lawrence
Sherman, Matthew, Elle.
Allen, Lee, F.
Strass, Lewis, Sea.
Application Number:
JP2007502952A
Publication Date:
October 11, 2007
Filing Date:
March 09, 2005
Export Citation:
Assignee:
Wyeth
International Classes:
A61K39/395; A61K31/436; A61K31/4745; A61K31/539; A61P35/00
Attorney, Agent or Firm:
Hiroshi Kobayashi
Eiji Katayama
Norio Omori
Yasuhito Suzuki
Eiji Katayama
Norio Omori
Yasuhito Suzuki